Physician profile
Daniel Denis
NPI 1154852978
$804.49
in general payments reported to CMS, 2019-2025
9 companies · $339 in 2025
The $339 reported for 2025 was more than what 88% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $414 · 2024: $52.12 · 2025: $339.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $804.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $804.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $193.41 | 2023 | |
| Enablecv INC. | $167.65 | 2025 | |
| Edwards Lifesciences Corporation | $166.77 | 2023-2025 | Mitris Resilia Mitral Valve, Hemosphere, Inspiris Resilia Aortic Valve |
| Abiomed | $140.32 | 2023-2025 | Impella |
| Medtronic, INC. | $40.60 | 2023 | Avalus |
| Pacira Pharmaceuticals Incorporated | $29.62 | 2024 | Iovera, Exparel |
| Silk Road Medical, INC. | $26.57 | 2023 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent |
| Haemonetics Corporation | $22.50 | 2024 | Teg6s Hemostasis System |
| Masimo Corporation | $17.05 | 2025 | Sedline |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Denis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.